A clinical study of LSD treatment in alcoholism
This randomised study (1969, n=176) found no long-lasting (up to 12 months later) positive effects of LSD-assisted therapy (210μg/70kg) versus no therapy, an effect that was found in other studies from this time.
Authors
- Lazar, R.
- Levine, J.
- Ludwig, A.
Published
Abstract
One hundred seventy-six male alcoholic patients participated in a controlled investigation of the differential efficacy of three LSD treatment procedures and a no therapy, or milieu treatment, condition. Half of each group was also assigned to disulfiram after discharge from the hospital to determine whether any of these techniques could be enhanced by its use. Although significant improvement was shown within all treatment groups as measured by a number of clinical assessments in the post-treatment and follow-up periods, no one treatment condition proved to be superior. The authors conclude that the dramatic claims for the efficacy of LSD treatment in alcoholism are unjustified.
Research Summary of 'A clinical study of LSD treatment in alcoholism'
Study Details
- Study Typeindividual
- Populationhumans
- Characteristicsrandomizedparallel groupfollow up
- Journal
- Compounds
Cited By (31)
Papers in Blossom that reference this study
Elmahy, N., Hernandez, A. V., Schiff, B. et al. · Current Medical Research and Opinion (2023)
Baker, P., Bright, S. J., Bruno, R. et al. · Journal of Psychopharmacology (2022)
Baron, T., Bhatt, S. R., Bogenschutz, M. P. et al. · JAMA Psychiatry (2022)
Agin-Liebes, G. I., Davis, A. K., España, M. et al. · Journal of Psychoactive Drugs (2021)
Bogenschutz, M. P., Duane, J. H., Malone, T. C. et al. · Spirituality in Clinical Practice (2021)
Berghella, A. P., Garcia-Romeu, A., Hendricks, P. S. et al. · International Journal of Drug Policy (2021)
Garcia-Romeu, A., Johnson, M. W., Strickland, J. C. · ACS Pharmacology and Translational Science (2020)
Andersen, K. A. A., Carhart-Harris, R. L., Erritzoe, D. et al. · Acta Psychiatrica Scandinavica (2020)
Hendricks, P. S., Nichols, C. D. · Handbook of Behavioral Neuroscience (2020)
Elices, M., Farré, M., Fonseca, F. et al. · Frontiers in Psychiatry (2020)
Show all 31 papersShow fewer
Davis, A. K., Erowid, E., Erowid, F. et al. · Journal of Psychopharmacology (2019)
Barrett, F. S., Griffiths, R. R., Hendricks, P. S. et al. · Pharmacology and Therapeutics (2019)
Garcia-Romeu, A., Richards, W. A. · International Review of Psychiatry (2018)
Carhart-Harris, R. L., Erritzoe, D., Haijen, E. C. H. M. et al. · Journal of Psychopharmacology (2018)
Iliff, J., Nutt, D. J., Rucker, J. · Neuropharmacology (2017)
Griffiths, R. R., Johnson, M. W. · Neurotherapeutics (2017)
Preller, K. H., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)
Cabral, J., Canal, C. E., Murnane, K. S. · Journal of Psychopharmacology (2016)
Bogenschutz, M. P., Forcehimes, A. A. · Journal of Humanistic Psychology (2016)
Barnwal, P., Das, S., Mondal, S. et al. · Therapeutic Advances in Psychopharmacology (2016)
McKenna, D., Riba, J. · Current Topics in Behavioral Neurosciences (2016)
Kometer, M., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)
Garcia-Romeu, A., Griffiths, R. R., Johnson, M. W. · Current Drug Abuse Reviews (2015)
Gallinat, J., Majic, T., Schmidt, T. T. · Journal of Clinical Psychopharmacology (2015)
Barbosa, P., Bogenschutz, M. P., Forcehimes, A. A. et al. · Journal of Psychopharmacology (2015)
Cosimano, M. P., Garcia-Romeu, A., Griffiths, R. R. et al. · Journal of Psychopharmacology (2014)
Bogenschutz, M. P. · Current Drug Abuse Reviews (2013)
Bogenschutz, M. P., Pommy, J. A. · Drug Testing and Analysis (2012)
Johansen, P. Ø., Krebs, T. S. · Journal of Psychopharmacology (2012)
Mangini, M. · Journal of Psychoactive Drugs (2011)
Griffiths, R. R., Johnson, M. W., Richards, W. A. · Journal of Psychopharmacology (2008)